Email Updates

You are here

AVAC's Blog: P-Values

  • Recent announcements from two ongoing PrEP trials, PROUD and IPERGAY, add to the body of evidence that TDF/FTC (Truvada) for HIV prevention is safe and effective. Check out the coverage including what, if anything, the news means for PrEP access in Europe, the plans for the trials moving forward and more.

    November 7, 2014
  • AVAC’s November 6 webinar on “The State of the HIV Prevention Union” will build on last week’s HIV Research for Prevention (R4P) conference—the first meeting to gather all the fields of biomedical prevention research under one roof. From broadly-neutralizing antibodies to building trust between trial participants and research teams—R4P had it all. Register now to keep the conversation going.

    November 4, 2014
  • The Center for Strategic and International Studies hosted “Ending Epidemics Through Technology: Developing an HIV Vaccine,” featuring a keynote presentation by Dr. Anthony Fauci, Director of the US National Institute of Allergy and Infectious Diseases, which was followed by a discussion with Margie McGlynn, President and CEO of the International AIDS Vaccine Initiative and Mitchell Warren, Executive Director of AVAC.

    November 4, 2014
  • Greetings from the fourth and final day of the HIV R4P conference! Read highlights from the conference and information about the individual sessions. And we are tweeting all the latest news and photos

    October 31, 2014
  • Greetings from the third day of the HIV R4P conference! Each day AVAC will be providing a dispatch with highlights from the conference. Read on for information about the plenary speeches and individual sessions. And we are tweeting all the latest news and photos

    October 30, 2014
  • Charles Brown reflects on the important role of advocates in prevention research and what they need to succeed. This post was written for the WhatsUpHIV blog, which reported in real time on the 2014 HIV Research for Prevention conference in Cape Town, South Africa.

    October 30, 2014
    Charles Brown, 2014 AVAC Advocacy Fellow
  • Yvette Raphael critiques researchers' efforts to engage young women at the 2014 HIV Research for Prevention (HIV R4P) conference. She challenges how researchers talk about women "lying" about adherence and expresses frustration at the difficulty of getting these researchers to participate in a conversation about this. This post was written for the WhatsUpHIV blog, which reported in real time on the 2014 HIV Research for Prevention conference in Cape Town, South Africa.

    October 30, 2014
    Yvette Raphael, 2014 AVAC Advocacy Fellow
  • PrEP took centerstage at the morning plenaries at HIV R4P—and while the talks were going on, the French research agency announced that the IPERGAY trial of intermittent ("on demand") PrEP would be discontinuing randomization and placebo control after strong preliminary evidence of efficacy. This blog post gives a look at both developments.

    October 29, 2014
    AVAC
  • Greetings from the second day of the HIV R4P conference! Each day AVAC will be providing a dispatch with highlights from the conference. Read on for information about the plenary speeches and individual sessions. And we are tweeting all the latest news and photos. Follow us!

    October 29, 2014
  • Definate Nhamo and Teresia Njoki Otieno report on key conversations around women's HIV prevention. They discuss research findings on adherence in ARV-based prevention trials and the evolving body of evidence on hormonal contraceptive use and HIV risk. They also highlight the perspectives of young women who participated in the conference. This post was written for the WhatsUpHIV blog, which reported in real time on the 2014 HIV Research for Prevention conference in Cape Town, South Africa.

    October 29, 2014
    Teresia Njoki Otieno, 2014 AVAC Advocacy Fellow
    Definate Nhamo, 2014 AVAC Advocacy Fellow

Pages